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INTRODUCTION 
The systemic delivery of drugs through novel 
methods of administration is one area in which significant 
changes and improvements have been made. 
Consequently, precise control of drug input into the body 
by a variety of routes is now possible. Controlled and 
sustained release formulations have been developed and 
are gaining in popularity and medical acceptance. 
Sustained release dosage forms are designed to release 
a drug at a predetermined rate in order to maintain a 
constant drug concentration for a specific period of time 
with minimum side effects. The advantage of 
administering a single dose of a drug that is released over 
an extended period of time to maintain a near-constant or 
uniform blood level of a drug often translates into better 
patient compliance, as well as enhanced clinical efficacy of 
the drug for its intended use
1
. Acyclovir is an antiviral 
drug, it is given in conventional dosage form five times a 
day hence frequent administration is the major problem 
associated with it. Moreover the major absorption site is 
from stomach and upper part of the intestine.  The drugs 
with a narrow absorption window in GIT or acting locally 
in the stomach, the challenging task is not only to prolong 
drug release but retention of the dosage form in the upper 
GIT. This result in a higher bioavailability, reduced time 
interval for drug administration and thus better patient 
compliance. Matrix technologies have often proven 
popular among the oral controlled drug delivery 
technologies because of their simplicity, ease in 
manufacturing, high level of reproducibility, stability of 
the raw materials and dosage form, ease of scale-up and 
process validation. The primary goal of mucoadhesive 
controlled drug delivery system is to localize a delivery 
device with the body to enhance the drug absorption 
process in a specific manner and to facilitate intimate 
contact of the dosage form with underlying absorption 
surface to improve and enhance the bioavailability of 
drugs
2
. In the present study an attempt was made to 
develop sustain release mucoadhesive matrix tablet of 
acyclovir using polymers like HPMC K15M, carbopol 
934P and ethyl cellulose, thereby enhancing the 
bioavailability of selected drug and to optimize the process 
variables and additives for the preparation of matrix tablets 
with desirable physicochemical and in vitro release 
characteristic. 
MATERIALS 
Acyclovir was a gift sample from Cipla Ltd, 
Bangalore. Ethyl cellulose was purchased from Himedia. 
Laboratories Pvt. Ltd, Mumbai.  Carbopol 934P, Micro 
crystalline cellulose, HPMC K15M   were procured from 
Loba chemie, Mumbai. All reagents used were of 
analytical grade. 
METHODS 
Drug Excipient Compatibility Studies 
FT-IR spectra matching approach was used for 
detection of any possible chemical interaction between the 
acyclovir and polymers. The samples were ground, mixed 
thoroughly with KBr and compressed at a    pressure of 
15tons /cm
2
. Samples were prepared for acyclovir, 
polymers such as ethyl cellulose, carbopol934, HPMC 
K15M and the physical mixtures of drug with polymers.  
The spectra obtained were compared and interpreted for 
the functional group peaks. 
Preformulation Studies 
The flow properties of granules were 
characterized in terms of angle of repose, Carr's index and 
Hausner's ratio. The bulk density and tapped density were 
determined and from this data Carr's index and Hausner's 
ratio were calculated.
3, 4, 5
. 
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Formulation of Mucoadhesive Matrix Tablet of 
Acyclovir 
 Matrix tablets of acyclovir were prepared by 
direct compression technology. The formulations 
composition is shown in Table 1.  All the powders were 
passed through a 40 mesh sieve. The required quantity of 
drug, various polymer mixtures and diluents were mixed. 
The blend was lubricated with magnesium stearate and 
compressed using (10.5 mm diameter round, flat and plain 
punches) multiple punch rotary tablet machine. In total, 10 
formulations containing different amounts of HPMC 
K15M (F1, F2, F3), Carbopol 934 (F4, F5, F6) and 
combination of HPMC K4 M or Carbopol 934 with ethyl 
cellulose (F7, F8, F9, F10) were prepared. All the tablets 
were stored in airtight containers for further study. 
Table1: Composition of mucoadhesive matrix tablet of acyclovir prepared by direct compression 
Ingredients 
F1 
(mg) 
F2 
(mg) 
F3  
(mg) 
F4 
(mg) 
F5  
(mg) 
F6 
(mg) 
F7 
(mg) 
F8 
(mg) 
F9 
(mg) 
F10 
(mg) 
Acyclovir 200 200 200 200 200 200 200 200 200 200 
HPMC K15M 69 92 115 - - - 57.5 - 46 - 
Carbopol 934P 
- 
 
- - 69 92 115 - 57.5 - 46 
Ethyl cellulose - - - - - - 57.5 57.5 69 69 
Microcrystalline 
cellulose 
185.5 162.5 139.5 185.5 162.5 139.5 139.5 139.5 139.5 139.5 
Magnesium stearate 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 5.5 
Total(mg) 460 460 460 460 460 460 460 460 460 460 
 
Characterization of Matrix Tablets  
Thickness 
  Five randomly selected tablets from each batch 
were used for thickness determination. The thickness of 
each tablet was measured in mm using a screw gauge their 
values were reported in millimeters. The mean and SD 
were calculated and reported. 
Weight Variation Test 
Twenty tablets were randomly selected from each 
batch and individually weighed using an electronic balance 
(Ohaus). The    average weight was calculated. The 
percentage deviation from average weight was reported.   
Hardness 
The resistance of the tablet to chipping, abrasion 
or breakage under conditions of storage, transportation and 
handling before usage, depends on its hardness. The 
hardness of six randomly selected tablets from each batch 
was measured using Monsanto Hardness tester and 
expressed in Kg/cm
2
. The average mean and SD were 
calculated
6
. 
Friability 
Friability of tablets was performed by using 
Roche friabilator. The tablets should be carefully dedusted 
prior to testing. Six tablets were randomly selected from 
each batch and accurately weigh the tablet sample, and 
place the tablets in the drum. Rotate the drum 100 times, 
and remove the tablets, re-weighed and percentage loss 
was determined. 
Drug Content Estimation 
  Five tablets were weighed individually and 
average was calculated and grounded in a mortar with 
pestle to get fine powder. An amount equivalent to 50 mg 
of drug was extracted with 100 ml of 0.1 N HCl. The 
solution was filtered through a filter paper (Whatman 0.22-
μm pore size), properly diluted with phosphate buffer of 
pH 6.8 and the drug content was determined by UV 
spectrophotometer at a wavelength 224 nm and the 
percentage drug content was calculated. 
Swelling Studies 
The extent of swelling was measured in terms of 
percentage weight gain by the tablet. Tablets were 
accurately weighed and placed in the basket of USP 
dissolution apparatus II; rotating at 50 rpm and 0.1 N HCl 
was used as medium. The temperature was maintained at 
37 ± 0.5°C. At the end of 5h, the tablet was withdrawn, 
soaked with tissue paper and weighed
7
. The percentage 
increase in weight due to absorbed liquid or water uptake 
was estimated at each time point.  
Measurment of Bioadhesive Strength 
The mucoadhesive strength was determined by 
using modified balance test and it was examined using 
chicken pouch as a mucosal membrane. The tissue was 
obtained from local slaughter house and stored frozen in 
Kreb’s buffer solution. This apparatus comprised of a two 
arm balance, one side of which contains glass plates and 
the other side contained a container. One of the two glass 
plates was attached permanently to the base of the stage, 
and the other was attached to the arm of the balance by a 
thick a strong thread. Fresh chicken buccal mucosa was 
glued to the upper side of the lower plate and another was 
glued to the lower side of the upper plate using 
cyanoacrylate adhesive. The tablet was placed on the 
chicken cheek mucosa glued to the upper side of the lower 
plate. Then, the upper plate was placed over the lower 
plate and 100 g preload force (or contact pressure) was 
applied for 5 min (preload time). After removal of the 
preload force, the water was kept in a bottle at some height 
and was siphoned into the container at a rate till the plates 
were detached from each other. The weight required to 
detach the buccal tablet from the mucosal surface gave the 
measure of mucoadhesive strength in gm
8
. 
Tablet Adhesion Retention Period 
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An agar plate (1%, w/w) was prepared in 0.1 N 
HCl (pH 1.2). A side of the tablet was wetted with 50 μl of 
0.1 N HCl and attached to the center of agar plate by 
applying a light force with a fingertip for 20 s. Five 
minutes later, the agar plate was attached to a USP 
disintegration test apparatus (model TDL-082 electrolab) 
and moved up and down in 0.1 N HCl (pH 1.2) at 37 ± 0.2 
°C. The adhering tablet on the plate was immersed into the 
solution at the lowest point and got out of the solution at 
the highest point. The retention period of the tablet on the 
plate was noted visually. 
In Vitro Drug Release Studies 
  In vitro drug release studies were performed by 
using USP dissolution apparatus type II [Electrolab (TDT-
08L). The drug release profile was studied in 900 ml of 
0.1N HCl buffer of pH 1.2 at 37 ± 0.2 °C. Rotational speed 
of the paddle was 50 rpm.  Aliquots of 5 ml of dissolution 
medium were withdrawn at specific time intervals, filtered 
and replaced with fresh medium. The absorbance of the 
samples was measured by UV spectrophotometer 
(Shimadzu UV 1800) at 256 nm.  
Drug Release Kinetics 
To find out the mechanism of drug release from 
matrix tablets, the in vitro release data was treated with 
different kinetic models, namely zero order, first order, and 
Higuchi. A criterion for selecting the most appropriate model 
was based on goodness of fit, high regression coefficient 
values. 
Stability Studies 
 According to ICH Q1A (R2), “the purpose of 
stability testing is to provide evidence on how the quality 
of a drug substance or drug product varies with time under 
the  
influence of a variety of environmental factors such as 
temperature, humidity and light”.  The selected 
formulations were subjected to stability studies up to 8 
weeks at different storage conditions. The tablets were 
sealed in airtight aluminium foil packets and stored at 
controlled room temperature condition (25 ± 2 °C and 60 ± 
5% RH) in a desiccator and at accelerated condition (40 ± 
2 °C and 75 ± 5% RH) in stability chamber. The drug 
content of the formulations was studied as per the 
specifications and compared with its initial drug content. 
RESULTS AND DISCUSSION 
Drug Excipient Compatibility Studies 
The results showed that the principle IR peak of 
pure drug, its physical mixture with polymer were almost 
similar, signifying no interaction between drug and 
polymer during formulation of tablets. 
Preformulation Studies of Powders 
The prepared powders were characterized for angle 
of repose, bulk density, tapped density, Hausner factor and 
Carr’s compressibility index and the values were reported in 
Table 2. The angle of repose of the different batches of 
powders was determined as per method mentioned earlier 
and results ranged between 16.65° to 19.89°. The powder 
with angle of repose less than 20° indicates excellent flow 
properties. The bulk densities of powder were ranged 
between 0.410 g/cm
3
 to 0.481 g/cm
3
. The low bulk density 
is due to the presence of more fines in powder. Tapped 
density ranged between 0.434 g/cm
3
 to 0.534 g/cm
3
. The 
percentage compressibility, an indirect method of 
measuring powder flow ability developed by Carr, was 
calculated and it is in good agreement with the results of 
angle of repose and Hausner Factor. All these results 
indicated that the powder possesses excellent flow 
properties and compressibility.  
 
Table 2: Physical properties of acyclovir blend with different excipients 
Formulation 
code 
Angle of 
Repose(°) 
Bulk density 
(g/cm
3 
) 
Tapped 
density(g/cm
3
) 
Hausner factor 
Carr’s index 
(%) 
F1 16.65 0.410 0.434 1.05 5.52 
F2 17.43 0.425 0.451 1.06 5.76 
F3 19.23 0.445 0.483 1.08 7.86 
F4 17.11 0.449 0.481 1.07 6.65 
F5 18.67 0.455 0.503 1.10 9.54 
F6 19.89 0.481 0.534 1.11 9.92 
F7 18.55 0.434 0.466 1.07 6.86 
F8 19.11 0.444 0.492 1.10 9.75 
F9 17.47 0.421 0.445 1.05 5.39 
F10 18.45 0.439 0.478 1.08 8.15 
 
Formulation of Mucoadhesive Matrix Tablets of 
Acyclovir  
In the present study, mucoadhesive matrix tablets 
of acyclovir were prepared by direct compression method 
using various polymers. Different formulations were given 
in Table 1. Ethyl cellulose, Carbopol 934 and HPMC K15M 
were used as polymers. During preparation, drug, lubricants, 
glidants and compression pressure were kept constant to 
avoid any possible influence of these factors. 
EVALUATION OF MATRIX TABLETS  
Weight Variation and Thickness Variation Test 
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The results of weight variation, thickness were 
represented in Table 3. The thickness of the prepared 
tablets was uniform and ranged between 4.692 ± 0.071 mm 
to 4.841 ± 0.085 mm. Also, it was observed that increasing 
the polymer concentrations resulted in slight decrease in 
the thickness of the tablet formulations. These results 
might indicate that the polymers have high binding 
properties. A tablet with carbopol 934P showed slight 
reduction in thickness that is due to high binding 
properties. The weights of the prepared tablets were 
ranging from 1.773 ± 0.34 to 2.314 ± 0.93.  
Hardness, Friability and Drug Content Estimation  
The results of hardness, friability and drug 
content estimation were reported in Table 3. Hardness of 
the tablets fell into the range 5.51 ± 0.16 kg/cm
2
 to 6.29 ± 
0.17 kg/cm
2
. The hardness of tablets made of carbopol 
934P found to be highest. For all the formulations, 
friability ranged from 0.18% to 0.38% indicating that the 
friability is within the prescribed limit of 1%.  The 
percentage drug content of matrix tablets from each batch 
was found to be uniform and ranged from 97.34 ± 0.95 % 
to 99.45 ± 0.33%.  
                     Table 3: Post compression parameters of mucoadhesive matrix tablets of acyclovir 
Formulation 
code 
Thickness* (mm) Hardness* 
(kg/cm
2
) 
Friability (%) % Weight 
variation^ 
% Drug    
content* 
F1 4.841±0.085 5.51±0.16 0.38 2.314±0.93 99.21±0.34 
F2 4.802±0.056 5.63±0.18 0.31 1.977±0.54 98.78±0.45 
F3 4.776±0.067 5.77±0.21 0.27 2.214±0.55 98.55±0.39 
F4 4.712±0.061 6.07±0.12 0.29 2.113±0.89 99.07±0.81 
F5 4.703±0.064 6.11±0.22 0.21 1.887±1.13 98.88±0.77 
F6 4.692±0.071 6.29±0.17 0.18 2.072±0.89 98.56±0.91 
F7 4.733±0.074 5.59±0.14 0.26 2.117±0.95 97.34±0.95 
F8 4.794±0.077 6.13±0.11 0.19 2.034±0.45 97.89±0.65 
F9 4.812±0.081 5.65±0.25 0.23 2.045±0.57 98.34±0.27 
F10 4.753±0.066 6.03±0.17 0.21 1.773±0.34 99.45±0.33 
* All values expressed in mean ± SD, n=6 
^ All values expressed in mean ± SD, n=20 
Swelling Studies  
 The influence of drug on the swelling properties 
of the polymer matrices is primarily dependent on the 
substituted groups of the polymer. Swelling of the matrix, 
which is indicated by the transition of the polymer from 
the glassy to the rubbery state, is an important parameter in 
the determination of the release characteristics of the 
matrix system. As the swelling process proceeds, the gel 
layer gradually becomes thicker and therefore the drug 
concentration gradient along the diffusional path length is 
decreased resulted in slower drug release rates. The effect 
of acyclovir on the swelling behavior of various 
mucoadhesive polymers was observed and swelling index 
ranging from 11.95 to 32.60. The results of swelling 
studies were represented in Table 4. 
Measurement of Bioadhesion Force and Tablet 
Adhesion Retention Time 
The mucoadhesive strength of tablet was 
dependent on the property of the bioadhesive polymers, 
which on hydration adhere to the mucosal surface and also 
on the concentration of polymer used. Bioadhesive force 
values ranged from 20601 (dynes/cm2) to 49050 
(dynes/cm2). The in vitro retention time is one of the 
important physical parameter of mucoadhesive tablet 
which was recorded as per the procedure mentioned above. 
Retention time values were ranging from 3.5 h to 8.5 h. 
The result showed that, as the concentration of 
mucoadhesive polymer increased the retention time was 
also increase 
Table 4: Swelling studies and Bioadhesive force of the tablets 
 
In Vitro Drug Release Studies 
The in vitro drug release profiles of formulations 
are illustrated in (Figure 1, Figure 2 and Figure 3). In vitro 
drug release from matrix systems depends on several 
factors, such as the manufacturing process, the type of 
excipients, drug solubility, polymer concentration and pH 
of the dissolution medium. It was found that the drug 
release from the patches varied with respect to the 
proportion of polymers. Preliminary studies showed that 
increase in the polymer concentration reduced the 
Formulation Code 
Swelling in Weight (mg) after 
5h 
Swelling Index Bioadhesive Force (dynes/cm
2
) 
F1 519 12.82 20601 
F2 521 13.26 29430 
F3 550 19.56 39240 
F4 545 18.47 32373 
F5 580 26.08 40221 
F6 610 32.60 49050 
F7 531 15.43 28740 
F8 540 17.39 32232 
F9 515 11.95 27444 
F10 520 13.04 30112 
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diffusion of the drug from the matrix. If the viscosity 
increases, the entrapment of drug is tightly bound in 
between the cross-links of the polymer; there by drug will 
take time to release from the patches. From the results it 
can be concluded that there was an increase in the extend 
of duration of drug release with increase in concentration 
of polymer in the formula. A perusal of (Figure 1) it can be 
seen that formulations F1, F2 and F3 loaded with 15%, 
20% and  25 % of the HPMC K15M released 90% of the 
drug over 6h,and 8 h respectively. No significant 
difference in release rate was observed between tablets 
containing either 15% or 20% of HPMC K4 M. Drug 
release was decreased significantly in the formulation 
containing 25% of HPMC K4 M. It  can be seen that 
formulations F4, F5 and F6 (Figure 2) loaded with 15%, 
20% and  25% of the carbopol 934P released 90% of the 
drug over 5h, 5h and 7h respectively.  Tablets containing 
25% of carbopol 934 were able to form the gelatinous 
layer around the tablet core and the drug release was found 
to be 97.39% within 7 h of dissolution study. Therefore, in 
order to control the initial burst release, ethyl cellulose was 
included in the matrix of the next batch of tablets in the 
ratio of 1:1 along with HPMC K4 M (F7) or carbopol 934 
(F8) which resulted in extending the drug release for a 
period of 10 h indicating fair uniform drug release 
throughout the dissolution period (Fig 3). This may be due 
to a more rigid complex structure formed by hydrophilic 
polymers (HPMC K4 M and carbopol 934) in presence of 
ethyl cellulose, which helped in retaining the drug in the 
matrix and hindering rapid diffusion of soluble drug from 
the matrix. Increasing the concentration of ethyl cellulose 
shows more retardation in the release of the drug from the 
formulation (F9) and (F10) containing ethyl cellulose in 
combination with HPMC K4 M and carbopol 934 in the 
ratio 1:1.5, respectively. F9 showed 40.91% and  F10 
showed only 43.93% of drug release in 10 h of dissolution 
study which may result in therapeutic failure of the 
formulation. 
 
Figure 1:  In vitro drug release profile of acyclovir tablets 
made from HPMC K15M polymer 
 
Figure 2: In vitro drug release profile of acyclovir tablets 
made from carbopol 934P polymer 
 
Figure 3: In vitro drug release profile of acyclovir tablets 
made from HPMC K15M, carbopol 934P and ethyl cellulose 
Kinetic Analysis of Drug Release Data 
Kinetic analysis of drug release data was done by 
using the software PCP Dissolution v2.08. It   was found 
that the formulation F1, F2, F3, F7, F8 and F10 followed 
zero order release and formulations F4, F5, F6 and F9 
followed first order release. The data of the various models 
revealed that formulations F4, F5, F6 and F10 followed 
Higuchi-Matrix model whereas formulations F1, F2, F3, 
F7, F8, F9, follows Korsmeyer-Peppas model. In case of 
formulation F4, F5, F6 the n value for Korsmeyer-Peppas 
model was found to be in range less than 0.5, which 
indicates mechanism of drug release by Fickian diffusion 
whereas in case of formulations F1, F2, F3, F7, F8, F9 and 
F10 the n value for Korsmeyer-Peppas model was found to 
be more than 0.5, which indicates mechanism of drug 
release by Non Fickian diffusion by those formulations. 
Stability Studies 
Different formulations of acyclovir matrix tablets 
were observed for any changes in color and general 
appearance for 8 weeks. There was no significant change 
found at the end of 8 weeks. The drug content of different 
formulations measured at every 2 weeks didn’t show any 
significant changes from their initial drug content values 
indicating that the formulations are stable.  
CONCLUSION 
In the present work, an attempt has been made 
formulating mucoadhesive matrix tablets of acyclovir 
using various hydrophillic polymers such as HPMC 
K15M, carbopol 934P and hydrophobic polymers such as 
ethyl cellulose. Effects of these polymers on matrix tablets 
of acyclovir were investigated. Kinetic studies were also 
carried out on different formulations. According to 
Korsmeyer Peppas, F1, F2, F3, F7, F8, F9 and F10 showed 
non fickian diffusion. While F4, F5 and F6 followed 
fickian diffusion. Stability studies revealed that all the 
formulation was found to be stable under accelerated 
stability studies. 
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